All trading involves risk. Losses can exceed deposits.

Japan 225 the index to watch this week

The Nikkei is solidifying its position above the 18,000 barrier and I feel this could be the index to watch this week. 

All trading involves risk. Losses can exceed deposits.
Japan
Source: Bloomberg

Japanese equities have managed to keep extending gains despite some yen consolidation; while there isn’t much out of Japan this week, I feel moves in USD/JPY could play a key role. On the USD side of the equation, traders will be eyeing Janet Yellen’s testimony very closely. While she is more likely to mirror the minutes from last week, I feel she’ll deliver a mostly balanced testimony. Any mention of moving towards policy normalisation is likely to be construed as a hawkish sign. This would see USD/JPY squeeze a bit higher and would also have a bearing on the Nikkei.

As a result, I feel buying the dips in the Nikkei, particularly around 18,100 could be traders’ strategy this week. Stops would have to be placed below 18,000 and I will update the parameters once the trade is triggered. 

Japan 225 chart

Japan 225 chart
Source: IG charts

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Find articles by analysts